These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21789592)

  • 1. Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity.
    Yan X; Zhang X; Wang Y; Li X; Wang S; Zhao B; Li Y; Ju Y; Chen L; Liu W; Meng S
    Cancer Immunol Immunother; 2011 Dec; 60(12):1763-74. PubMed ID: 21789592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treg suppress CTL responses upon immunization with HSP gp96.
    Liu Z; Li X; Qiu L; Zhang X; Chen L; Cao S; Wang F; Meng S
    Eur J Immunol; 2009 Nov; 39(11):3110-20. PubMed ID: 19839010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic depletion of CCR8
    Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses.
    Zheng H; Liu L; Zhang H; Kan F; Wang S; Li Y; Tian H; Meng S
    PLoS One; 2019; 14(1):e0211490. PubMed ID: 30703157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
    Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
    Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
    Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
    Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice.
    Liu Y; Peng Y; Mi M; Guevara-Patino J; Munn DH; Fu N; He Y
    J Immunol; 2009 May; 182(10):5960-9. PubMed ID: 19414747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.
    Saha A; Chatterjee SK
    Scand J Immunol; 2010 Feb; 71(2):70-82. PubMed ID: 20384858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
    Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts.
    Poehlein CH; Haley DP; Walker EB; Fox BA
    Eur J Immunol; 2009 Nov; 39(11):3121-33. PubMed ID: 19839008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity.
    Alvarez Arias DA; Kim HJ; Zhou P; Holderried TA; Wang X; Dranoff G; Cantor H
    Cancer Immunol Res; 2014 Mar; 2(3):207-16. PubMed ID: 24778317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration of a mesothelioma by IFN-gamma-producing cells and tumor rejection after depletion of regulatory T cells.
    Rudge G; Barrett SP; Scott B; van Driel IR
    J Immunol; 2007 Apr; 178(7):4089-96. PubMed ID: 17371963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.
    Mattarollo SR; Steegh K; Li M; Duret H; Foong Ngiow S; Smyth MJ
    Immunol Cell Biol; 2013 Jan; 91(1):105-14. PubMed ID: 23090488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation.
    Li X; Liu Z; Yan X; Zhang X; Li Y; Zhao B; Wang S; Zhou X; Gao GF; Meng S
    PLoS One; 2013; 8(7):e68997. PubMed ID: 23874845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
    Goforth R; Salem AK; Zhu X; Miles S; Zhang XQ; Lee JH; Sandler AD
    Cancer Immunol Immunother; 2009 Apr; 58(4):517-30. PubMed ID: 18719913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining a peptide vaccine with oral ingestion of Lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing mice.
    Tanaka K; Ishikawa S; Matsui Y; Kawanishi T; Tamesada M; Harashima N; Harada M
    Cancer Immunol Immunother; 2012 Nov; 61(11):2143-52. PubMed ID: 22588648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.